Related Experiment Video
Updated: Jan 30, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays
Wenfang Zhou1, Mojie Duan2, Weitao Fu3
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; State Key Laboratory of Computer Aided Design and Computer Graphics (CAD&GC), Zhejiang University, Hangzhou 310058, China.
Abstract:
Androgen receptor (AR) is a ligand-activated transcription factor that plays a pivotal role in the development and progression of many severe diseases such as prostate cancer, muscle atrophy, and osteoporosis. Binding of ligands to AR triggers the conformational changes in AR that may affect the recruitment of coactivators and downstream response of AR signaling pathway. Therefore, AR ligands have great potential to treat these diseases. In this study, we searched for novel AR ligands by performing a docking-based virtual screening (VS) on the basis of the crystal structure of the AR ligand binding domain (LBD) in complex with its agonist. A total of 58 structurally diverse compounds were selected and subjected to LBD affinity assay, with five of them (HBP1-3, HBP1-17, HBP1-38, HBP1-51, and HBP1-58) exhibiting strong binding to AR-LBD. The IC50 values of HBP1-51 and HBP1-58 are 3.96 µM and 4.92 µM, respectively, which are even lower than that of enzalutamide (Enz, IC50 = 13.87 µM), a marketed second-generation AR antagonist. Further bioactivity assays suggest that HBP1-51 is an AR agonist, whereas HBP1-58 is an AR antagonist. In addition, molecular dynamics (MD) simulations and principal components analysis (PCA) were carried out to reveal the binding principle of the newly-identified AR ligands toward AR. Our modeling results indicate that the conformational changes of helix 12 induced by the bindings of antagonist and agonist are visibly different. In summary, the current study provides a highly efficient way to discover novel AR ligands, which could serve as the starting point for development of new therapeutics for AR-related diseases.
Insights
Researchers identified novel androgen receptor (AR) ligands using virtual screening. Two compounds, HBP1-51 (agonist) and HBP1-58 (antagonist), show potent binding, offering potential for AR-related disease therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Androgen receptor (AR) is crucial in diseases like prostate cancer.
- AR ligand binding induces conformational changes affecting signaling.
- Targeting AR with novel ligands offers therapeutic potential.
Purpose of the Study:
- To discover novel androgen receptor (AR) ligands.
- To identify compounds with high affinity for the AR ligand-binding domain (LBD).
- To characterize the agonist/antagonist activity and binding mechanisms of new ligands.
Main Methods:
- Docking-based virtual screening of diverse compounds.
- AR-LBD affinity assays to identify binders.
- Bioactivity assays, molecular dynamics (MD) simulations, and principal components analysis (PCA).
Main Results:
- Five compounds showed strong binding to AR-LBD.
- HBP1-51 and HBP1-58 exhibited potent AR binding (IC50 < enzalutamide).
- HBP1-51 acts as an AR agonist, HBP1-58 as an AR antagonist, with distinct conformational changes observed.
Conclusions:
- A virtual screening approach efficiently identified novel AR ligands.
- HBP1-51 and HBP1-58 are promising lead compounds for AR-related diseases.
- Understanding ligand-induced conformational changes aids in therapeutic development.
Related Concept Videos
Internal Receptors
Ligand Binding and Linkage
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Olfactory Receptors: Location and Structure
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

